glp 1 agonist in india agonists price GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo India's GLP-1 Boom: Tread with

Consumers should stay informed about current regulatory guidance before making purchasing decisions

Potential weight loss figures are not guarantees and depend on clinical eligibility, adherence, dosing, and individual factors

United States Demand for GLP-1 receptor agonists in the United States is forecasted to advance at 5.2% CAGR through 2036

Despite some states offering limited coverage of GLP-1s to treat weight loss as far back as a decade ago, most states that currently provide coverage through taxpayer-funded Medicaid programs or state employee health plans have only opted to do so within the past five years

While this decline could be attributed to multiple factorschanging social norms, economic pressures, or generational shiftsthe timing aligns closely with the rise of these medications